SAB Biotherapeutics, Inc.SABSNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Cash generated from core business operations

Percentile
P0
Near historical low
vs 5Y Ago
-4.5x
Contraction
Streak
5 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$-44.78M-30.6%
2024$-34.29M-36.5%
2023$-25.12M-7.1%
2022$-23.46M-1280.7%
2021$1.99M-80.1%
2020$10.00M+208.6%
2019$-9.21M-